Call 800 665 0411 to learn about our services for your stock

Search   Follow Investorideas on Twitter   Investorideas is on Facebook   Investorideas is on Youtube   Investorideas is on Pinterest  Investorideas is on stocktwits   Investorideas is on tumblr   Investorideas is on LinkedIn   Investorideas Instagram   Investorideas Telegram   Investorideas Gettr   Investorideas RSS

Share on StockTwits

Cannabis News: New Frontier Data Expands Scientific Reporting with Appointment of Prominent Cannabis Scientist, Reggie Gaudino, as Chief Science Advisor


WASHINGTON - September 6, 2019 ( Newswire) New Frontier Data, the global authority in data, analytics and business intelligence for the cannabis industry, announced today the appointment of Dr. Reggie Gaudino as chief science advisor. In his new role, Dr. Gaudino will advise, guide and participate in internal and external discussions pertinent to the science and medicine of cannabis, strengthening New Frontier Data's scientific perspective and thought leadership in what is becoming a global medicinal cannabis market.

"Dr. Gaudino is one of the most prominent science-based thought leaders in the cannabis industry"

"Dr. Gaudino is one of the most prominent science-based thought leaders in the cannabis industry," said New Frontier Data Founder and CEO Giadha Aguirre de Carcer. "He is an internationally recognized scientific voice in cannabis, and his expertise will raise the already-high bar of New Frontier Data's rigorous research and analytics offerings."

Dr. Gaudino will continue his scientific research and development efforts, working to better understand and apply cannabis for medical use. Previously, Dr. Gaudino played a vital role in building out the cannabis genetics and research division at Steep Hill, Inc., a cannabis and science technology company. His leadership led to the development of the first commercially offered cannabis DNA-based sex test, and subsequently the first commercially offered cannabis DNA-based CBD test, GenKit™.

Some of Dr. Gaudino's early achievements include serving as a patent agent with Sequenom to bring valuable insights particularly in cannabis genetics to the industry. Before then, he founded and served as president of Gaudino & Associates, providing intellectual property contract services to clients.

"Elevating the discussion on the need for collection protocols, source vetting, and unbiased and accurate analytics to best understand and predict cannabis markets fluctuations, New Frontier Data has led the way to improved cannabis data reporting standards. I'm thrilled to lend my expertise as they continue to advance market knowledge of this now global industry," said Dr. Gaudino. "As worldwide interest in cannabis expands, the need for scientific research and understanding follows suit."

About New Frontier Data:

New Frontier Data is an independent, technology-driven analytics company specializing in the cannabis industry. It offers vetted data, actionable business intelligence and risk management solutions for investors, operators, researchers and policymakers. New Frontier Data's reports and data have been cited in over 80 countries around the world to inform industry leaders. Founded in 2014, New Frontier Data is headquartered in Washington, D.C. with additional offices in Denver, CO, and London, U.K.

New Frontier Data does not take a position on the merits of cannabis legalization. Rather, its mission and mandate are to inform cannabis-related policy and business decisions through rigorous, issue-neutral and comprehensive analysis of the legal cannabis industry worldwide. For more information about New Frontier Data, please visit:

Media Contact:

Caroline Kowalski
1-844-420-3882 ext. 3

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: Learn more about publishing your news release and our other news services on the newswire and

Global investors must adhere to regulations of each country. Please read privacy policy:

Follow Us on StockTwits

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories for Cannabis stocks and Psychedelic Stocks

Buy a cannabis guest post on